Skip to main content

Défaut de glycosylation des glycoprotéines (CDG)

  • Chapter
  • 837 Accesses

Résumé

Les anomalies congénitales de glycosylation ou CDG (Congenital Disorders of Glycosylation) forment une classe d’erreurs innées du métabolisme, affectant la synthèse des glycannes des glycoprotéines [1, 2]. La glycosylation fait partie des modifications post-traductionnelles et concerne différents types de structures glycannes, la plus connue étant la N-glycosylation.

This is a preview of subscription content, access via your institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Grunewald S, Matthijs G, Jaeken J (2002) Congenital disorders of glycosylation: a review. Pediatr Res 52: 618–24

    PubMed  Google Scholar 

  2. Jaeken J (2003) Komrower Lecture. Congenital disorders of glycosylation (CDG): it’s all in it! J Inherit Metab Dis 26: 99–118

    PubMed  CrossRef  CAS  Google Scholar 

  3. Jaeken J, Carchon H (2004) Congenital disorders of glycosylation: a booming chapter of pediatrics. Curr Opin Pediatr 16: 434–9

    PubMed  CrossRef  Google Scholar 

  4. Harms HK, Zimmer KP, Kurnik K, et al. (2002) Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency. Acta Paediatr 91: 1065–72

    PubMed  CrossRef  CAS  Google Scholar 

  5. Mention K, Lacaille F, Valayannopoulos V, et al. (2008) Development of liver disease despite mannose treatment in two patients with CDG-Ib. Mol Genet Metab 93: 40–3

    PubMed  CrossRef  CAS  Google Scholar 

  6. De Zegher F, Jaeken J (1995) Endocrinology of the carbohydrate-deficient glycoprotein syndrome type 1 from birth through adolescence. Pediatr Res 37: 395–401

    PubMed  CrossRef  Google Scholar 

  7. Stibler H, Blennow G, Kristiansson B, et al. (1994) Carbohydrate-deficient glycoprotein syndrome: clinical expression in adults with a new metabolic disease. J Neurol Neurosurg Psychiatry 57: 552–6

    PubMed  CrossRef  CAS  Google Scholar 

  8. Liem YS, Bode L, Freeze HH, et al. (2008) Using heparim therapy to reverse protein-losing enterapathy in a patient with CDG-Ib. Nat Clin Pract Gastroenterol Hepatol 5(4): 220–4

    PubMed  CrossRef  Google Scholar 

  9. Monagle P, Chan AK, Goldenberg NA, et al (2012) Antithrombotic therapy in neonates and children. Chest 141(2): e737S–e801S

    PubMed  CrossRef  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

Copyright information

© 2013 Springer-Verlag France

About this chapter

Cite this chapter

De Lonlay, P., Dubois, S., Valayannopoulos, V., Depondt, E., Ottolenghi, C., Rabier, D. (2013). Défaut de glycosylation des glycoprotéines (CDG). In: Prise en charge médicale et diététique des maladies héréditaires du métabolisme. Springer, Paris. https://doi.org/10.1007/978-2-8178-0046-2_23

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0046-2_23

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0045-5

  • Online ISBN: 978-2-8178-0046-2

  • eBook Packages: MedicineMedicine (R0)